Randomized PhaseII/III Trial of XL-184 versus Liposomal Doxorubicin in Recurrent Platinum Resistant/Refractory Peritoneum
Latest Information Update: 06 Oct 2011
At a glance
- Drugs Cabozantinib (Primary) ; Doxorubicin liposomal (Primary)
- Indications Gynaecological cancer; Peritoneal cancer
- Focus Therapeutic Use
- 06 Oct 2011 New trial record